Fresh Equities
ASX:ANR

ASX:ANR

ANATARA LIFESCIENCES LTD

4W AVG VOLUME
64.39k
Data provided by Weblink | as of close 2020-01-28
4W AVG TURNOVER
$18.04k

ANATARA LIFESCIENCES LTD has not announced any current capital raises, but we are collecting interest for future raises.

Demand Registered for Next Raise
< $50k
Investors Interested in Next Raise
< 10
How Fresh Equities Works
Authentication

1. Create Account

Complete your onboarding digitally in less than 3 minutes.

Authentication

2. View Terms

View the full term sheet for the capital raise.

Authentication

3. Bid for Allocation

Submit and track your bid online.

Capital Raise History

Loading...


Company Overview

Anatara Lifesciences Ltd (ANR) is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Company's initial focus is the development and commercialisation of Detach, which is a natural, plant-based, non-antibiotic therapy that prevents and treats diarrhoea in pigs.

Type

Listed Company

GICS Sub-industry

Biotechnology

Head Office

433 Logan Rd, Greenslopes QLD 4120, Australia

Biotechnology
Health Care
Biotech & Health

Price Chart


Quarterly Cash Flows

The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.

Loading...


Directors


Announcements

All
All Time
  • Anatara Preclinical Program Summary on 22 January 2020

    Progress Report

  • Change in substantial holding on 19 January 2020

    Shareholder Details

    Appendix 3B on 15 January 2020

    Issued Capital

  • Appendix 4C - quarterly on 14 January 2020

    Commitments test entity quarterly reports

  • Anatara finalises draft protocol for IBS Clinical Trial on 19 December 2019

    Progress Report

  • Anatara achieves preclinical milestone on 19 December 2019

    Progress Report

  • Appendix 3B on 11 December 2019

    Issued Capital

    Anatara Investor Presentation and Update on 27 November 2019

    Periodic Reports

    Change of Director's Interest Notice on 25 November 2019

    Shareholder Details

    Appendix 3B on 25 November 2019

    Issued Capital

    Load More

News

Loading...